Acute administration of catalase targeted to ICAM-1 attenuates neuropathology in experimental traumatic brain injury
Abstract Traumatic brain injury (TBI) contributes to one third of injury related deaths in the US. Treatment strategies for TBI are supportive, and the pathophysiology is not fully understood. Secondary mechanisms of injury in TBI, such as oxidative stress and inflammation, are points at which inter...
Main Authors: | Evan M. Lutton, Roshanak Razmpour, Allison M. Andrews, Lee Anne Cannella, Young-Jin Son, Vladimir V. Shuvaev, Vladimir R. Muzykantov, Servio H. Ramirez |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2017-06-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-017-03309-4 |
Similar Items
-
Dexamethasone Attenuates the Enhanced Rewarding Effects of Cocaine Following Experimental Traumatic Brain Injury
by: Steven F. Merkel, et al.
Published: (2017-07-01) -
Endothelial Targeted Strategies to Combat Oxidative Stress: Improving Outcomes in Traumatic Brain Injury
by: Evan M. Lutton, et al.
Published: (2019-06-01) -
Engineered Dual Antioxidant Enzyme Complexes Targeting ICAM-1 on Brain Endothelium Reduce Brain Injury-Associated Neuroinflammation
by: Brian M. Leonard, et al.
Published: (2024-02-01) -
Mechanical injury induces brain endothelial-derived microvesicle release: Implications for cerebral vascular injury during traumatic brain injury
by: Allison M. Andrews, et al.
Published: (2016-02-01) -
Icam-1 targeted nanogels loaded with dexamethasone alleviate pulmonary inflammation.
by: M Carme Coll Ferrer, et al.
Published: (2014-01-01)